Faster, Further - Reliability and substainably : a new product offert for recombinant Factor C Endotoxin Testing
PDA Global Microbiology Meeting • Bethesda • 2018
The vast majority of endotoxin tests for pharmaceuticals and medical devices as well as their in-process intermediates and raw materials are microplate-based. They require tedious reconstitution and dilution steps for preparation of Control Standard Endotoxin (CSE) dilutions and Positive Product Controls (PPCs). These time-consuming manual handling steps can result in substantial variability and a significant rate of invalid results that demand repeat testing [...]
TO DOWNLOAD THE POSTER, PLEASE COMPLETE THIS FORM
Written by
Petra
R&D Manager
Healthcare Business Industry Unit
Hyglos GmbH - a bioMérieux company
Written by
Martin
Scientific
Healthcare Business Industry Unit
Hyglos GmbH - a bioMérieux company
Written by
Gregory
Endotoxin program director
Healthcare Business Industry Unit
bioMérieux SA, France
Written by
Thomas
SUBSCRIBE TO OUR PHARMA & HEALTHCARE NEWSLETTER
* Mandatory fields
Stay up to date with market & technology insights, latest products & services #bioMérieux industrial microbiology
Do you need to talk to our microbiology experts to find the right solution for you, to know if the product is available in your country ?